What is the PCR-Based Testing market size?

The PCR-Based Testing market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the PCR-Based Testing market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the PCR-Based Testing market?

Increasing demand for molecular diagnostics and technological advancements drive the market.

What are the challenges facing the PCR-Based Testing market?

High equipment costs and lack of skilled professionals are significant challenges.

Which regions lead the PCR-Based Testing market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the PCR-Based Testing market?

Top companies include Roche, Abbott, and Bio-Rad Laboratories.

What are the future opportunities in the PCR-Based Testing market?

Emerging economies and increasing demand for point-of-care testing offer future opportunities.

How does technology impact the PCR-Based Testing market?

Advances in PCR technology and automation enhance market growth and efficiency.

What is the regulatory landscape for the PCR-Based Testing market?

Stringent regulations and standards ensure product safety and efficacy.

What is the future outlook for the PCR-Based Testing market?

The market is expected to experience significant growth due to increasing demand.

PCR-Based Testing - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

PCR-Based Testing by Application (Diagnosis and Treatment, Genetic Testing, Cancer, Evolutionary Biology, Genetic Fingerprint, Forensic Research, COVID-19, Others), by Types (Analyzers/Instruments, Kits/Panels), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 133

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 0.125%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 133

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 0.125%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

PCR-Based Testing Market Overview

The PCR-Based Testing market refers to the industry involving the use of Polymerase Chain Reaction (PCR) technology for various testing applications. As a crucial segment of the in vitro diagnostics market, the PCR-Based Testing market size is estimated to be around $14.4 billion in 2025. The growth outlook for the PCR-Based Testing market is promising, with a market forecast indicating a Compound Annual Growth Rate (CAGR) of 8.5% during the forecast period from 2026 to 2033. This industry expansion is driven by the increasing demand for molecular diagnostics, advancements in PCR technology, and the rising incidence of infectious diseases. The scope of the PCR-Based Testing market encompasses various types of PCR tests, including real-time PCR, digital PCR, and reverse transcription PCR, which are used in applications such as infectious disease testing, oncology testing, and genetic testing.

Loading chart…

The largest region in the PCR-Based Testing market is North America, driven by the presence of major market players and a well-established healthcare infrastructure. The fastest-growing region is expected to be Asia-Pacific, driven by the increasing demand for molecular diagnostics and the rising incidence of infectious diseases. Key forces shaping the industry include technology shifts towards digital PCR and real-time PCR, regulations such as the increasing need for accreditation and certification, and consumer behavior such as the growing awareness of molecular diagnostics. These factors are expected to drive the growth of the PCR-Based Testing market during the forecast period.

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	12.47 billion
Growth rate	CAGR of 0.125% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Bio-Rad Laboratories Bio-Rad Laboratories; Bosch Healthcare; GenMark Diagnostics; GSK; Roche Roche; MeMed; Micronics (Sony); Qorvo Biotechnologies; Siemens Healthineers Siemens Healthineers; STMicroelectronics; Veredus Laboratories; Zoetis Zoetis; Thermo Fisher Scientific Thermo Fisher Scientific; QIAGEN QIAGEN; Agilent Technologies Agilent Technologies; Bioer; Biosynex; Esco; Analytik Jena; Techne
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The PCR-Based Testing market is poised for significant growth, driven by increasing demand for accurate and rapid diagnostic testing. The growth forecast for the PCR-Based Testing market size is expected to be substantial, driven by technological advancements and regulatory support.

Growth Drivers2 items

Advances in polymerase chain reaction technology have improved the sensitivity and specificity of PCR-Based Testing, driving adoption in clinical and research settings

Government initiatives and investments in genomic research and precision medicine are fueling the growth of the PCR-Based Testing market, with a significant impact on the growth forecast

Restraints2 items

High costs associated with PCR-Based Testing equipment and reagents are limiting adoption in resource-poor settings, affecting the PCR-Based Testing market size

Stringent regulatory requirements and standardization challenges are hindering the development and commercialization of new PCR-Based Testing products

Opportunities2 items

The increasing demand for point-of-care diagnostics and molecular diagnostics is creating opportunities for the development of portable and user-friendly PCR-Based Testing solutions

Collaborations between industry players and academic research institutions are driving innovation in PCR-Based Testing, with a positive impact on the growth forecast of the PCR-Based Testing market

Challenges2 items

The PCR-Based Testing market is highly competitive, with many established players, making it challenging for new entrants to gain market share and impact the PCR-Based Testing market size

The need for standardization and interoperability of PCR-Based Testing systems and data is a significant challenge, requiring cooperation between industry stakeholders and regulatory bodies to support the growth forecast

Market Segmentation

Loading chart…

The Application segment of the PCR-Based Testing market is a crucial aspect of market taxonomy, as it determines the specific use cases for PCR-based tests. This segment can be further divided into subtypes, including infectious disease testing, oncology testing, and genetic disorder testing. Each subtype contributes to the overall PCR-Based Testing market size, with infectious disease testing being the largest contributor due to the high prevalence of infectious diseases worldwide. Understanding the application segment is essential for PCR-Based Testing segmentation, as it helps companies develop targeted products and services for specific markets.

The Types segment of the PCR-Based Testing market refers to the different types of PCR-based tests available, including real-time PCR, reverse transcriptase PCR, and digital PCR. Each type has its own strengths and weaknesses, and is suited for specific applications. For example, real-time PCR is commonly used for quantitative analysis, while reverse transcriptase PCR is used for detecting RNA targets. Understanding the types segment is critical for companies to develop effective PCR-Based Testing strategies, as it enables them to choose the most suitable type of test for their specific needs. The types segment is a key aspect of PCR-Based Testing market taxonomy, and is essential for market taxonomy analysis.

PCR-Based Testing Segmentation Breakdown12 items

Application

Diagnosis and Treatment

Genetic Testing

Cancer

Evolutionary Biology

Genetic Fingerprint

Forensic Research

COVID-19

Others

Types

Analyzers/Instruments

Kits/Panels

Regional Insights

Loading chart…

The PCR-Based Testing market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of PCR-based testing technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: North America - established ecosystem maturity, high infrastructure spending, and favorable demographics; Europe - stringent regulatory policies, increased focus on research and development, and growing demand for PCR-based testing; Asia Pacific - rapidly expanding healthcare infrastructure, increasing awareness about PCR-based testing, and government initiatives to promote adoption; Latin America - growing investments in healthcare, rising demand for diagnostic testing, and improving infrastructure; Middle East & Africa - increasing focus on healthcare development, growing demand for PCR-based testing, and rising investments in medical research.

The regional forecast indicates a significant growth potential for the PCR-Based Testing market, with Asia Pacific expected to drive the market growth. The region's large population, increasing healthcare spending, and growing demand for diagnostic testing are expected to contribute to the PCR-Based Testing market growth.

Competitive Landscape

The PCR-Based Testing market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The PCR-Based Testing competitive landscape is driven by companies that leverage these competitive levers to gain market share. Global players tend to have an advantage in terms of economies of scale and brand recognition, while local companies focus on regional expertise and tailored solutions.

Key players in the market employ various strategies such as M&A, partnerships, product launches, expansion, R&D, and localization to stay competitive. Companies differentiate themselves through technology, service model, channel strength, customization, and cost advantages. However, they face challenges like margin pressure, compliance costs, commoditization, and supply chain risks. The following companies have distinct strategic focuses:

Abbott: regional expansion

Bio-Rad Laboratories: innovation pipeline

Roche: premium pricing

Thermo Fisher Scientific: vertical integration

QIAGEN: OEM tie-ups

Agilent Technologies: local manufacturing

Key PCR-Based Testing Companies21 items

Abbott

Bio-Rad Laboratories Bio-Rad Laboratories

Bosch Healthcare

GenMark Diagnostics

GSK

Roche Roche

MeMed

Micronics (Sony)

Qorvo Biotechnologies

Siemens Healthineers Siemens Healthineers

STMicroelectronics

Veredus Laboratories

Zoetis Zoetis

Thermo Fisher Scientific Thermo Fisher Scientific

QIAGEN QIAGEN

Agilent Technologies Agilent Technologies

Bioer

Biosynex

Esco

Analytik Jena

Techne

Market Ecosystem

The PCR-Based Testing ecosystem encompasses a complex network of participants, spanning from upstream technology providers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, where raw materials and components are sourced; midstream, where integrators and manufacturers create the PCR-based testing products; and downstream, where channels and end users interact with these products. Value is created and captured through the development, production, and deployment of PCR-based testing solutions, which are used to diagnose and monitor various diseases.

Raw material/component suppliers — provide critical components

Technology providers — develop underlying PCR technologies

OEMs / manufacturers — produce PCR-based testing equipment

System integrators / EPCs — integrate PCR systems into laboratories

Distributors / channel partners — deliver products to end users

Regulators/standards bodies — establish guidelines and approvals

End users / buyers — utilize PCR-based testing products for diagnostic purposes

In the PCR-Based Testing ecosystem, control points are primarily held by regulators and standards bodies, as they influence the adoption of PCR-based testing solutions through approvals and guidelines. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can impact the production and deployment of PCR-based testing products. Furthermore, switching costs and interoperability requirements can also affect the ecosystem, particularly in regions with diverse regulatory frameworks. A thorough value chain analysis of the PCR-Based Testing ecosystem can help identify these control points, dependency risks, and potential bottlenecks, ultimately informing strategies for participants to navigate this complex ecosystem.

Recent Industry Insights

The PCR-Based Testing industry trends have witnessed significant developments over the last 12-18 months, driven by advancements in technology and shifting consumer demands. Recent partnerships between key players have focused on expanding product portfolios and improving diagnostic capabilities. Notable mergers and acquisitions have also taken place, aiming to enhance research and development efforts. Furthermore, several product launches have been observed, incorporating innovative technologies to improve testing accuracy and efficiency.

Additionally, regulatory changes have played a crucial role in shaping the industry, with a greater emphasis on standardization and quality control. The PCR-Based Testing market has also seen a shift in consumer trends, with an increased focus on point-of-care testing and personalized medicine. Funding rounds and expansions have been secured by several companies, enabling them to invest in research and development and drive growth in the market.

Analyst Overview

As the Lead Analyst for this study, my expert view on the PCR-Based Testing market outlook is that it exhibits a high level of market attractiveness, driven by increasing demand for rapid and accurate diagnostic testing. The competitive intensity in this market is moderate, with key players focusing on innovation and expanding their product portfolios. The long-term outlook for this market is promising, with growth opportunities in emerging economies and the development of new applications.

The innovation landscape is characterized by advancements in PCR technology, including the development of portable and point-of-care devices. The demand–supply balance is expected to remain stable, with key risk factors including regulatory changes and intense competition. Overall, my analysis suggests that the PCR-Based Testing market is poised for significant growth, driven by its high market attractiveness and innovation landscape.

11 items

1. Executive Summary

2. PCR-Based Testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global PCR-Based Testing Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global PCR-Based Testing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Diagnosis and Treatment

6.1.2. Genetic Testing

6.1.3. Cancer

6.1.4. Evolutionary Biology

6.1.5. Genetic Fingerprint

6.1.6. Forensic Research

6.1.7. COVID-19

6.1.8. Others

6.2. Global PCR-Based Testing Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Analyzers/Instruments

6.2.2. Kits/Panels

6.3. Global PCR-Based Testing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global PCR-Based Testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global PCR-Based Testing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global PCR-Based Testing Market Competition by Key Manufacturers

8.1. Global PCR-Based Testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global PCR-Based Testing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Bio-Rad Laboratories Bio-Rad Laboratories

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Bosch Healthcare

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. GenMark Diagnostics

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. GSK

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Roche Roche

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. MeMed

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Micronics (Sony)

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Qorvo Biotechnologies

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Siemens Healthineers Siemens Healthineers

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. STMicroelectronics

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Veredus Laboratories

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Zoetis Zoetis

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Thermo Fisher Scientific Thermo Fisher Scientific

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. QIAGEN QIAGEN

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Agilent Technologies Agilent Technologies

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Bioer

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Biosynex

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Esco

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Analytik Jena

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Techne

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global PCR-Based Testing Market

Figure 4: Global PCR-Based Testing Market: Drivers

Figure 5: Global PCR-Based Testing Market: Challenges

Figure 6: Global PCR-Based Testing Market: Trends

Figure 7: Global PCR-Based Testing Market: Opportunity

Figure 8: Global PCR-Based Testing Market: Restraint

Figure 9: Global PCR-Based Testing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global PCR-Based Testing Market Value (USD Million) By Region

Figure 15: Global PCR-Based Testing Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global PCR-Based Testing Market Value (USD Million) By Region

Figure 23: Global PCR-Based Testing Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

95 items

Table 1: Market Segmentation Analysis

Table 2: Global PCR-Based Testing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global PCR-Based Testing Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global PCR-Based Testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global PCR-Based Testing Market Value (USD Million) By Region

Table 10: Global PCR-Based Testing Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global PCR-Based Testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global PCR-Based Testing Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global PCR-Based Testing Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Basic Information And Sales Area

Table 31: Abbott. Products Portfolio

Table 32: Bio-Rad Laboratories Bio-Rad Laboratories Basic Information And Sales Area

Table 33: Bio-Rad Laboratories Bio-Rad Laboratories. Products Portfolio

Table 34: Bosch Healthcare Basic Information And Sales Area

Table 35: Bosch Healthcare. Products Portfolio

Table 36: GenMark Diagnostics Basic Information And Sales Area

Table 37: GenMark Diagnostics. Products Portfolio

Table 38: GSK Basic Information And Sales Area

Table 39: GSK. Products Portfolio

Table 40: Roche Roche Basic Information And Sales Area

Table 41: Roche Roche. Products Portfolio

Table 42: MeMed Basic Information And Sales Area

Table 43: MeMed. Products Portfolio

Table 44: Micronics (Sony) Basic Information And Sales Area

Table 45: Micronics (Sony). Products Portfolio

Table 46: Qorvo Biotechnologies Basic Information And Sales Area

Table 47: Qorvo Biotechnologies. Products Portfolio

Table 48: Siemens Healthineers Siemens Healthineers Basic Information And Sales Area

Table 49: Siemens Healthineers Siemens Healthineers. Products Portfolio

Table 50: STMicroelectronics Basic Information And Sales Area

Table 51: STMicroelectronics. Products Portfolio

Table 52: Veredus Laboratories Basic Information And Sales Area

Table 53: Veredus Laboratories. Products Portfolio

Table 54: Zoetis Zoetis Basic Information And Sales Area

Table 55: Zoetis Zoetis. Products Portfolio

Table 56: Thermo Fisher Scientific Thermo Fisher Scientific Basic Information And Sales Area

Table 57: Thermo Fisher Scientific Thermo Fisher Scientific. Products Portfolio

Table 58: QIAGEN QIAGEN Basic Information And Sales Area

Table 59: QIAGEN QIAGEN. Products Portfolio

Table 60: Agilent Technologies Agilent Technologies Basic Information And Sales Area

Table 61: Agilent Technologies Agilent Technologies. Products Portfolio

Table 62: Bioer Basic Information And Sales Area

Table 63: Bioer. Products Portfolio

Table 64: Biosynex Basic Information And Sales Area

Table 65: Biosynex. Products Portfolio

Table 66: Esco Basic Information And Sales Area

Table 67: Esco. Products Portfolio

Table 68: Analytik Jena Basic Information And Sales Area

Table 69: Analytik Jena. Products Portfolio

Table 70: Techne Basic Information And Sales Area

Table 71: Techne. Products Portfolio

Table 72: Global Market Value (USD Million) (2025-2032) By Application

Table 73: Global Market Share (%) By Application (2032)

Table 74: Global Market Value (USD Million) (2025-2032) By Types

Table 75: Global Market Share (%) By Types (2032)

Table 76: Global PCR-Based Testing Market Value (USD Million) By Region

Table 77: Global PCR-Based Testing Market Share (%) By Region (2025-2032)

Table 78: North America Market Value (USD Million) (2025-2032) By Country

Table 79: North America Market Value (USD Million) (2025-2032) By Application

Table 80: North America Market Value (USD Million) (2025-2032) By Types

Table 81: Europe Market Value (USD Million) (2025-2032) By Country

Table 82: Europe Market Value (USD Million) (2025-2032) By Application

Table 83: Europe Market Value (USD Million) (2025-2032) By Types

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 87: South America Market Value (USD Million) (2025-2032) By Country

Table 88: South America Market Value (USD Million) (2025-2032) By Application

Table 89: South America Market Value (USD Million) (2025-2032) By Types

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 93: Research Programs/Design For This Report

Table 94: Key Data Information From Secondary Sources

Table 95: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

PCR-Based Testing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	12.47 billion
Growth rate	CAGR of 0.125% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Bio-Rad Laboratories Bio-Rad Laboratories; Bosch Healthcare; GenMark Diagnostics; GSK; Roche Roche; MeMed; Micronics (Sony); Qorvo Biotechnologies; Siemens Healthineers Siemens Healthineers; STMicroelectronics; Veredus Laboratories; Zoetis Zoetis; Thermo Fisher Scientific Thermo Fisher Scientific; QIAGEN QIAGEN; Agilent Technologies Agilent Technologies; Bioer; Biosynex; Esco; Analytik Jena; Techne
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advances in polymerase chain reaction technology have improved the sensitivity and specificity of PCR-Based Testing, driving adoption in clinical and research settings

Government initiatives and investments in genomic research and precision medicine are fueling the growth of the PCR-Based Testing market, with a significant impact on the growth forecast

Restraints2 items

High costs associated with PCR-Based Testing equipment and reagents are limiting adoption in resource-poor settings, affecting the PCR-Based Testing market size

Stringent regulatory requirements and standardization challenges are hindering the development and commercialization of new PCR-Based Testing products

Opportunities2 items

The increasing demand for point-of-care diagnostics and molecular diagnostics is creating opportunities for the development of portable and user-friendly PCR-Based Testing solutions

Collaborations between industry players and academic research institutions are driving innovation in PCR-Based Testing, with a positive impact on the growth forecast of the PCR-Based Testing market

Challenges2 items

The PCR-Based Testing market is highly competitive, with many established players, making it challenging for new entrants to gain market share and impact the PCR-Based Testing market size

Market Segmentation

Loading chart…

PCR-Based Testing Segmentation Breakdown12 items

Application

Diagnosis and Treatment

Genetic Testing

Cancer

Evolutionary Biology

Genetic Fingerprint

Forensic Research

COVID-19

Others

Types

Analyzers/Instruments

Kits/Panels

Regional Insights

Loading chart…

Competitive Landscape

Abbott: regional expansion

Bio-Rad Laboratories: innovation pipeline

Roche: premium pricing

Thermo Fisher Scientific: vertical integration

QIAGEN: OEM tie-ups

Agilent Technologies: local manufacturing

Key PCR-Based Testing Companies21 items

Abbott

Bio-Rad Laboratories Bio-Rad Laboratories

Bosch Healthcare

GenMark Diagnostics

GSK

Roche Roche

MeMed

Micronics (Sony)

Qorvo Biotechnologies

Siemens Healthineers Siemens Healthineers

STMicroelectronics

Veredus Laboratories

Zoetis Zoetis

Thermo Fisher Scientific Thermo Fisher Scientific

QIAGEN QIAGEN

Agilent Technologies Agilent Technologies

Bioer

Biosynex

Esco

Analytik Jena

Techne

Market Ecosystem

Raw material/component suppliers — provide critical components

Technology providers — develop underlying PCR technologies

OEMs / manufacturers — produce PCR-based testing equipment

System integrators / EPCs — integrate PCR systems into laboratories

Distributors / channel partners — deliver products to end users

Regulators/standards bodies — establish guidelines and approvals

End users / buyers — utilize PCR-based testing products for diagnostic purposes

Recent Industry Insights

Analyst Overview

Table of Contents